Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg + IV methylprednisolone versus IVIg alone for induction treatment in CIDP
2017-002511-34Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing IVIg + IV methylprednisolone with IVIg + sodium chloride control (2 arms). Started Apr 2018; status: completed.
02
Drugs
immune globulinmethylprednisolone
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2017-002511-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002511-34.